Foghorn Therapeutics

+$0.23 (+1.90%) As of 3:10 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FHTX and other ETFs, options, and stocks.

About FHTX

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology.

CEO
Adrian Gottschalk
Employees
119
Headquarters
Cambridge, Massachusetts
Founded
2015

FHTX Key Statistics

Market cap
511.30M
Price-Earnings ratio
—
Dividend yield
—
Average volume
265.54K
High today
$12.37
Low today
$12.05
Open price
$12.05
Volume
5.30K
52 Week high
$24.34
52 Week low
$8.01

FHTX Earnings

-$3.12
-$1.24
$0.65
$2.53
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure